| Authors: |
Gopal AK; University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington. AGopal@u.washington.edu., Levy R; Stanford Cancer Center, Stanford, California., Houot R; 1 CHU Rennes, Service Hématologie Clinique Rennes, France.; University of Rennes, EFS, Microenvironment, Cell Differentiation, Immunology and Cancer Rennes, France.; INSERM 0203, Unité d'Investigation Clinique, Rennes, France., Patel SP; University of California at San Diego Moores Cancer Center, San Diego, California., Popplewell L; City of Hope National Medical Center, Duarte, California., Jacobson C; Dana-Farber Cancer Institute, Boston, Massachusetts., Mu XJ; Pfizer Oncology, San Diego, California., Deng S; Pfizer Oncology, San Diego, California., Ching KA; Pfizer Oncology, San Diego, California., Chen Y; Pfizer Oncology, San Diego, California., Davis CB; Pfizer Oncology, San Diego, California., Huang B; Pfizer Oncology, Groton, Connecticut., Fly KD; Pfizer Oncology, Groton, Connecticut., Thall A; Pfizer Oncology, San Diego, California., Woolfson A; Pfizer Oncology, New York, New York., Bartlett NL; Washington University School of Medicine, Siteman Cancer Center, St Louis, Missouri. |
